Paying users zone. Data is covered by 
.
Get 1 month access to Thermo Fisher Scientific Inc. for $17.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Thermo Fisher Scientific Inc. (TMO)
Liquidity Analysis
Difficulty: Beginner
Liquidity ratios measure the company’s ability to meet its short-term obligations.
Ratios (Summary)
Thermo Fisher Scientific Inc., liquidity ratios
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Current ratio | |
|
|
|
|
|
| Quick ratio | |
|
|
|
|
|
| Cash ratio | |
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
| Ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Thermo Fisher Scientific Inc.’s current ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Thermo Fisher Scientific Inc.’s quick ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Thermo Fisher Scientific Inc.’s cash ratio improved from 2016 to 2017 and from 2017 to 2018. |
Current Ratio
Thermo Fisher Scientific Inc., current ratio calculation, comparison to benchmarks
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Current assets | |
|
|
|
|
|
| Current liabilities | |
|
|
|
|
|
| Ratio | ||||||
| Current ratio1 | |
|
|
|
|
|
| Benchmarks | ||||||
| Current Ratio, Competitors2 | ||||||
| Becton, Dickinson & Co. | |
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
| Current Ratio, Sector | ||||||
| Health Care Equipment & Services | |
|
|
|
|
|
| Current Ratio, Industry | ||||||
| Health Care | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
1 2018 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
| Ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Thermo Fisher Scientific Inc.’s current ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
Quick Ratio
Thermo Fisher Scientific Inc., quick ratio calculation, comparison to benchmarks
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Cash and cash equivalents | |
|
|
|
|
|
| Accounts receivable, less allowances | |
|
|
|
|
|
| Total quick assets | |
|
|
|
|
|
| Current liabilities | |
|
|
|
|
|
| Ratio | ||||||
| Quick ratio1 | |
|
|
|
|
|
| Benchmarks | ||||||
| Quick Ratio, Competitors2 | ||||||
| Becton, Dickinson & Co. | |
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
| Quick Ratio, Sector | ||||||
| Health Care Equipment & Services | |
|
|
|
|
|
| Quick Ratio, Industry | ||||||
| Health Care | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
1 2018 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
| Ratio | Description | The company |
|---|---|---|
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Thermo Fisher Scientific Inc.’s quick ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
Cash Ratio
Thermo Fisher Scientific Inc., cash ratio calculation, comparison to benchmarks
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Cash and cash equivalents | |
|
|
|
|
|
| Total cash assets | |
|
|
|
|
|
| Current liabilities | |
|
|
|
|
|
| Ratio | ||||||
| Cash ratio1 | |
|
|
|
|
|
| Benchmarks | ||||||
| Cash Ratio, Competitors2 | ||||||
| Becton, Dickinson & Co. | |
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
| Cash Ratio, Sector | ||||||
| Health Care Equipment & Services | |
|
|
|
|
|
| Cash Ratio, Industry | ||||||
| Health Care | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).
1 2018 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
| Ratio | Description | The company |
|---|---|---|
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Thermo Fisher Scientific Inc.’s cash ratio improved from 2016 to 2017 and from 2017 to 2018. |